Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 24;9:433–442. doi: 10.2147/CEOR.S135065

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Gerace et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Cost (€) per patient by procedures and follow-up.

Notes: (A and B) Reported costs per patient by procedures and related follow-up. All costs are reported in Euros (2016) and include pretreatments as well as follow-up intervention costs. Considering the costs for drugs, the mean of the cost per person for chemotherapy with high-cost drugs is €10,147, including first- and second-line chemotherapy. In contrast, a complete scheme of chemotherapy with low-cost drugs amounts to €2,438 per person. Cystectomy and lymphadenectomy are the most significant procedures in terms of cost per patient, at a value of €16,843, followed by radiotherapy (€11,687), TUR (€3,130), BCG intravesical therapy (€1,341), and mitomycin C intravesical therapy (€1,189).

Abbreviations: BCG, Bacillus Calmette Guérin; TUR, transurethral resection.